KIT and neoplasm: By using SSEA4 as a negative selection marker to eliminate undifferentiated hESCs or immature daughter cells of early developmental stages, we prevented tumor formation and uncontrolled cell proliferation in our transplantation experiments, demonstrating the excellent safety features of C-Kit+ cells for potential clinical application.